I agree that this site is using cookies. You can find further informations here.
X
Carty, Shannon A.
50  results:
Search for persons X
?
1

ER-associated degradation adapter Sel1L is required for CD8..:

Correa-Medero, Luis O. ; Jankowski, Shayna E. ; Hong, Hanna S....
Cell Reports.  43 (2024)  5 - p. 114156 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Biological insights into the role of TET2 in T cell lymphom..:

Carty, Shannon A.
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

SOHO State of the Art Updates and Next Questions | New Path..:

Carty, Shannon A. ; Murga-Zamalloa, Carlos A. ; Wilcox, Ryan A.
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  8 - p. 561-574 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Adding venetoclax to lenalidomide and rituximab is safe and..:

Phillips, Tycel J. ; Bond, David ; Takiar, Radihka...
Blood Advances.  7 (2023)  16 - p. 4518-4527 , 2023
Link: https://doi.org/10.1182/..
 
?
5

Two cases of challenging cutaneous lymphoid infiltrates pre..:

Bresler, Scott C. ; Menge, Tyler D. ; Tejasvi, Trilokraj..
Journal of Cutaneous Pathology.  50 (2022)  3 - p. 213-219 , 2022
Link: https://doi.org/10.1111/..
 
?
6

The physical exam's role in determining dose-limiting toxic..:

Runge, John S. ; Brown, Anna B. ; Phillips, Tycel J....
Journal of Oncology Pharmacy Practice.  29 (2022)  3 - p. 601-602 , 2022
Link: https://doi.org/10.1177/..
 
?
7

Targeted Therapies for Follicular Lymphoma:

Girard, Jennifer ; Karimi, Yasmin ; Carty, Shannon...
Current Hematologic Malignancy Reports.  16 (2021)  1 - p. 25-31 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Germline POT1 variants can predispose to myeloid and lympho..:

Lim, Tristan L. ; Lieberman, David B. ; Davis, Adam R....
Leukemia.  36 (2021)  1 - p. 283-287 , 2021
Link: https://doi.org/10.1038/..
 
?
9

Clinical Application of Next Generation Sequencing in Lymph..:

Tokaz, Molly ; Scott, Anthony ; Devata, Sumana...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S255 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Evaluating Acalabrutinib In The Treatment Of Mantle Cell Ly..:

Girard, Jennifer ; Reneau, John ; Devata, Sumana...
OncoTargets and Therapy.  12 (2019)  - p. 8003-8014 , 2019
Link: https://doi.org/10.2147/..
 
?
11

Adult-onset hydroa vacciniforme-like lymphoma in a long-ter..:

Yu, Kenneth K. ; Franzblau, Lauren ; Fullen, Douglas R...
JAAD Case Reports.  4 (2018)  4 - p. 314-317 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Contributors:

, In: Hematology,
Abdel-Wahab, Omar ; Abrahm, Janet L. ; Adams, Sharon... - p. vii-xxi , 2018
Link: https://doi.org/10.1016/..
 
?
13

T-Cell Immunity:

, In: Hematology,
Carty, Shannon A. ; Riese, Matthew J. ; Koretzky, Gary A. - p. 221-239 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Disruption of TET2 promotes the therapeutic efficacy of CD1..:

Fraietta, Joseph A. ; Nobles, Christopher L. ; Sammons, Morgan A....
Nature.  558 (2018)  7709 - p. 307-312 , 2018
Link: https://doi.org/10.1038/..
 
?
15

Interleukin-4 Regulates Eomesodermin in CD8+ T Cell Develop..:

Carty, Shannon A. ; Koretzky, Gary A. ; Jordan, Martha S..
PLoS ONE.  9 (2014)  9 - p. e106659 , 2014
Link: https://doi.org/10.1371/..
 
1-15